Stephen F. Betz - 31 Dec 2024 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Signature
Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
31 Dec 2024
Net transactions value
+$6,756
Form type
5
Filing time
29 Jan 2025, 16:30:05 UTC
Previous filing
18 Dec 2024
Next filing
24 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $6,756 +451 +0.64% $14.98 71,358 20 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),